Real-World Evidence Outcomes in the Use of Bevacizumab in Age-Related Macular Degeneration (ArMD): A Scoping Review Protocol

Update Item Information
Title Real-World Evidence Outcomes in the Use of Bevacizumab in Age-Related Macular Degeneration (ArMD): A Scoping Review Protocol
Review Team Ainhoa Gomez-Lumbreras, Theodoros Giannouchos, Rupesh Panchal, Priyanka Ghule, Cate M. Lockhart, Diana Brixner
Organizational Affiliation University of Utah
Department or Division University of Utah College of Pharmacy; Biologics and Biosimilars Collective Intelligence Consortium
DOI https://doi.org/10.26052/0d-b3vq-8d5m
Citation Ainhoa Gomez-Lumbreras, Theodoros Giannouchos, Rupesh Panchal, Priyanka Ghule, Cate M. Lockhart, Diana Brixner. Real-world evidence outcomes in the use of bevacizumab in Age-Related Macular Degeneration (ArMD): a scoping review protocol. 2021. Protocol Registry of Evidence Reviews at the University of Utah. Available from DOI: https://doi.org/10.26052/0d-b3vq-8d5m
Country USA
Language eng
Date 2021
Date of Protocol April 23, 2021
Date Digital 2022
Type of Review Scoping Review
Type Text
Format application/pdf
Rights Management Copyright © 2022, University of Utah, All Rights Reserved
Subject Macular Degeneration; Evidence-Based Pharmacy Practice; Evidence-Based Medicine; Endothelial Growth Factors; Angiogenesis Inhibitors; Bevacizumab; Ranibizumab; Treatment Outcome; Systematic Reviews as Topic; Review Literature as Topic; Registries; Databases, Bibliographic; Meta-Analysis; Data Curation; Guideline Adherence
ARK ark:/87278/s6fpqdg3
Setname ehsl_esp
ID 1738259
Reference URL https://collections.lib.utah.edu/ark:/87278/s6fpqdg3
Back to Search Results